Ilfeld D, Feierman E, Kuperman O, Kivity S, Topilsky M, Netzer L, Pecht M, Trainin N
Immunology. 1984 Nov;53(3):595-8.
We examined the effect of oral colchicine (1-2 mg/day) on four healthy volunteers' T cell subsets. Colchicine significantly (P less than 0.01) decreased the mean (+/- SD) percent of OKT3+ total T cells (from 70 +/- 16 to 47 +/- 13), OKT4+ helper/inducer T cells (from 44 +/- 9 to 24 +/- 6), and OKT8+ suppressor/cytotoxic T cells (from 27 +/- 7 to 17 +/- 7), but did not significantly affect the OKT4:OKT8 ratio (from 1.64 +/- 0.21 to 1.48 +/- 0.45) or concanavalin A-induced suppressor cell function (from 44 +/- 9% to 47 +/- 13%). Thus, colchicine non-selectively decreased the circulating helper/inducer and suppressor/cytotoxic T cells.
我们研究了口服秋水仙碱(1 - 2毫克/天)对四名健康志愿者T细胞亚群的影响。秋水仙碱显著(P小于0.01)降低了OKT3 + 总T细胞的平均(±标准差)百分比(从70 ± 16降至47 ± 13)、OKT4 + 辅助/诱导性T细胞(从44 ± 9降至24 ± 6)以及OKT8 + 抑制/细胞毒性T细胞(从27 ± 7降至17 ± 7),但对OKT4:OKT8比值(从1.64 ± 0.21降至1.48 ± 0.45)或伴刀豆球蛋白A诱导的抑制细胞功能(从44 ± 9%降至47 ± 13%)没有显著影响。因此,秋水仙碱非选择性地降低了循环中的辅助/诱导性和抑制/细胞毒性T细胞。